Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept
In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aflibercept
Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept
The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July